Trial reportBMC public health2023
Say it right: measuring the impact of different communication strategies on the decision to get vaccinated.
Trial report in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review.Global health action · 2024Pooled it
- "As soon as it's trying to be persuasive, my skepticism kicks in": A qualitative study to co-design vaccine communication strategies with vaccine hesitant adults in Canada.Human vaccines & immunotherapeutics · 2026Article
- Interactive, Personalized Patient Decision Aid for COVID-19 Vaccination in Canada: User-Centered Design Approach.JMIR human factors · 2026Article
- Mpox and the Ethics of Outbreak Management: Lessons for Future Public Health Crises.Developing world bioethics · 2026Article
- Human Papillomavirus Vaccination Policies and Discourse on Social Media.JAMA health forum · 2026Article
- Communication strategies in childhood vaccine hesitancy: a scoping review.Revista de saude publica · 2026Article
- Child vaccine communication practice in promoting child immunization in the Amhara region of Ethiopia.World journal of clinical pediatrics · 2025Article
- Article
- Investigating Post-COVID-19 Risk Perception and Preventive Behaviour Among Individuals in Riyadh, Saudi Arabia.Cureus · 2025Article
- Article
- Factors Associated with Influenza and Pneumococcal Vaccine Hesitancy Among Patients with AECOPD: A Cross-Sectional Study in China Using the 3C Model.International journal of chronic obstructive pulmonary disease · 2025Article
- Impact of health promotion strategies on HPV vaccination uptake: A descriptive epidemiological study (2019-2024).PloS one · 2025Article
- Adherence to COVID-19 vaccination recommendations and vaccine hesitancy in US blood donors.Transfusion · 2024Article
- Determining factors for COVID-19 vaccine hesitancy among Brazilians: a study using structural equation modeling.Revista brasileira de enfermagem · 2024Observational
- Lessons learned from the COVID-19 pandemic: identifying hesitant groups and exploring reasons for vaccination hesitancy, from adolescence to late adulthood.Frontiers in public health · 2024Article
- Pervasive Parental Hesitancy and Resistance towards Measles Rubella Vaccination in Jordan.Vaccines · 2023Article
- Effects of a Message-Framing Video Intervention on Maternal Vaccine Confidence Regarding HPV Vaccination for Daughters: A Quasi-Experimental Study Among Mothers With Cervical Intraepithelial Neoplasia.Public health nursing (Boston, Mass.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVaccine hesitancy is a concerning menace to the control of vaccine-preventable diseases. Effective health communication could promote an overall understanding of the importance, risks, and benefits of vaccination and reduce vaccine hesitancy.
methodsIn this survey, four fictitious newspaper articles addressing an emerging bogus disease and its vaccine were randomly assigned to participants. The first version focused on information about the disease; the second was akin to the first, including a case description and image. The third version focused on vaccine safety/efficacy; the fourth version was like the third, including a case description and image. After reading a single version of the article, participants responded if they would take the vaccine and if they would vaccinate their children. We used chi-squared tests for comparisons and investigated interactions with vaccine-hesitant attitudes.
resultsWe included 5233 participants between August/2021 and January/2022; 790 were caregivers of a child ≤ 5 years old, and 15% had prior vaccine hesitancy. Although most declared intention to take the vaccine, the percentage was highest among those exposed to the newspaper article focusing on the vaccine safety/efficacy with the case description and picture (91%; 95% confidence interval 89-92%), and lowest among participants exposed to the article focusing on the disease with no case description (84%; 95% confidence interval 82-86%). Similar trends were observed in the intention of offspring vaccination. We found evidence of effect modification by vaccine-hesitant attitudes, with a higher impact of communication focusing on vaccine safety/efficacy compared to that focusing on disease characteristics among hesitant participants.
conclusionCommunication strategies focusing on different aspects of the disease-vaccine duet may impact vaccine hesitancy, and storytelling/emotive imagery descriptions may improve risk perception and vaccine uptake. Moreover, the effect of message framing strategies may differ according to previous vaccine hesitant attitudes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.